Valor IV Pharma Holdings, LLC
CIK 1821186 · last filed 2024-11-05
Valor IV Pharma Holdings, LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for HRMY, was dated Aug 7, 2026. Across all open-market trades the lifetime net is −$1.25B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $279.6M across reported positions. The firm reports its address in Chicago, IL. 5 SEC filings were submitted jointly with Antonio J. Gracias.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$279.61M
1
2
-$1.25B
Filer Profile
SUITE 3214
CHICAGO, IL 60611
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRMY | 10%+ Owner | 6,618,033 | $42.25 | $279.61M | -$1.25B | 1 | 2024-11-05 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-07 | HRMY | Notice (144) | −700,883 | -$26.56M | EDGAR |
| 2024-11-05 | HRMY | Sell (S) | −41,400,000 | -$1.25B | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.